News

Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results from in vitro studies evaluating the use of PTI-129 as a treatment for COVID-19. PTI-129...

LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials

LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has created COVID-19 Clinical Trial Connect in the U.S., a site designed to help people access...

Klockner Pentaplast Expands in North America to Support the Pharmaceutical Market

Klöckner Pentaplast, a manufacturer of pharmaceutical barrier packaging films, broke ground on a large expansion at its Klöckner Barrier Film (KBF) facility in central Virginia in the United States. The multi-million dollar investment will increase the facility’s capacity by 6,000...

Biocair Transports Plasmids For COVID-19 Research in South Africa

Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI) in Durban, South Africa. AHRI Faculty Member and Research Group Leader at the Max Planck Institute...

AstraZeneca’s Tagrisso Improved Disease-Free Survival in NSCLC with EGFR Mutations by 89%

AstraZeneca released detailed data from the Phase III ADAURA clinical trial of Tagrisso (osimertinib) in early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer, demonstrating what they call “unprecedented disease-free survival.” The company is presenting the study during...

Swisslog wins German Innovation Award 2020 with the ACPaQ mixed-case palletizing solution

The fully automated Swisslog ACPaQ palletizing solution has won the German Innovation Award 2020 in the “Machines & Engineering” category. This award compares existing solutions and awards outstanding achievements in innovation and honors solutions that distinguish themselves primarily by...

Thermo Fisher Scientific Announces Collaboration to Provide Access to Deep Learning Tools for Discovery and Targeted Proteomics

Thermo Fisher Scientific, the world leader in serving science, and MSAID GmbH, a software company transforming proteomics with deep learning, announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID’s Prosit-derived framework widely...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read